Daniel C. Chung, DO, MA
Advertisement
Chung is Chief Medical Officer of Beacon Therapeutics
Articles by Daniel C. Chung, DO, MA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA approves subcutaneous Enspryng for TED
2
AAO 2026: Vamikibart shows sustained gains in uveitic macular edema as FDA accepts BLA
3
EC-104 outperforms Ozurdex in phase 2 BETTIS-1 trial for anti-VEGF–resistant DME
4
OT Roundup: Optogenetics Nobel Prize, BRUNELLO, DRAGON, eye transplant
5